The IL‐17RA results for CRC are consistent with those for NSCLC, gastric cancer, and osteosarcoma, where high IL‐17RA expression was found to be associated with poor prognosis.4, 15, 16. This evidence concerns the gene IL17RA and colorectal carcinoma.